Appointment effective February 12 following Nadim Yared's retirement Hykes currently serves as Augmedics' President and CEO, and has served on CVRx's Board of Directors since 2022 MINNEAPOLIS, Jan. 31, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ:CVRX) ("CVRx"), a commercial-stage medical device company, announced today the appointment of Kevin Hykes as the Company's new President and Chief Executive Officer, effective February 12. Hykes will continue to serve on the Company's Board of Directors. Yared will ...

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Warrior Met Coal, Inc. (HCC) : This metallurgical coal mining company has seen the Zacks Consensus Estimate for its current year earnings increasing 9.9% over the last 60 days.Eldorado Gold Corporation (EGO) : This mining and exploration company has seen the Zacks Consensus Estimate for its current year earnings increasing 11.5% over the last 60 days.World Acceptance Corporation (WRLD) : This consumer finance company has seen the Zacks ...

CVRx, Inc. (NASDAQ:CVRX) Q4 2023 Earnings Conference Call January 25, 2024 4:30 PM ET Company Participants Mike Vallie - IR Nadim Yared - President and CEO Jared Oasheim - CFO Conference Call Participants Margaret Andrew - William Blair Matthew O'Brien - Piper Sandler Robbie Marcus - JPMorgan Bill Plovanic - Canaccord Alex Nowak - Craig-Hallum Frank Takkinen - Lake Street Operator Greetings, and welcome to the CVRx Fourth Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is ...

CVRx (CVRX) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $0.51 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 20%. A quarter ago, it was expected that this medical device company would post a loss of $0.57 per share when it actually produced a loss of $0.43, delivering a surprise of 24.56%.Over the last four quarters, the company has surpass ...

You should read this Quarterly Report on Form 10-Q and the documents that we reference in this Quarterly Report on Form 10-Q completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events ...

CVRx, Inc. (NASDAQ:CVRX) Q3 2023 Earnings Conference Call October 26, 2023 5:30 PM ET Company Participants Mike Vallie - SVP-ICR Westwicke Nadim Yared - President and CEO Jared Oasheim - CFO Conference Call Participants Matthew O'Brien - Piper Sandler Margaret Kaczor - William Blair Alex Nowak - Craig-Hallum Frank Takkinen - Lake Street Capital Markets Operator Greetings and welcome to the CVRx Third Quarter 2023 Earnings Call. At this time all participants are in listen-only mode. A question-and-answer ses ...

Table of Contents 8 CVRx, Inc. (the "Company") was incorporated in Delaware and is headquartered in Minneapolis, Minnesota. The Company has developed and is marketing a medical device, Barostim, for heart failure ("HF") and resistant hypertension. The Company is focused on the sale of its product in the U.S. and Europe. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. G ...

CVRx, Inc. (NASDAQ:CVRX) Q2 2023 Earnings Conference Call July 25, 2023 5:30 PM ET Company Participants Mike Vallie – Senior Vice President-ICR Westwicke Nadim Yared – President and Chief Executive Officer Jared Oasheim – Chief Financial Officer Conference Call Participants Matthew O’Brien – Piper Sandler Margaret Kaczor – William Blair Bill Plovanic – Canaccord Genuity Alex Nowak – Craig-Hallum Frank Takkinen – Lake Street Capital Markets Operator Greetings, and welcome to the CVRx Q2 2023 Earnings Call. A ...

As of March 31, 2023 and December 31, 2022, our cash and cash equivalents were maintained with two financial institutions in the U.S., and our current deposits are likely in excess of insured limits. We believe these institutions have sufficient assets and liquidity to conduct their operations in the ordinary course of business with little or no credit risk to us. Evaluation of disclosure controls and procedures Changes in internal control over financial reporting 28 Item 1. Legal Proceedings Item 1A. Risk ...

CVRx, Inc. (NASDAQ:CVRX) Q1 2023 Earnings Conference Call April 27, 2023 5:00 PM ET Company Participants Michael Vallie - Investor Relations Nadim Yared - President and Chief Executive Officer Jared Oasheim - Chief Financial Officer Conference Call Participants Will Plovanic - Canaccord Genuity Alex Nowak - Craig-Hallum Capital Group Frank Takkinen - Lake Street Capital Markets Operator Greetings, and welcome to the CVRx Q1 2023 Earnings Call. At this time, all participants are in a listen-only-mode. A brie ...